Search results for: 'next capture therapy'

07 Mar 2023  |  Global  |  Technology Research

Global Gut Microbiome Growth Opportunities

Targeted Gut Microbiome Technologies to Drive Transformational Growth Across the Global Healthcare Landscape

Infographics

×

This study identifies and analyzes research initiatives focused on the development of gut microbiome therapeutics. Disruption of the gut microbiome causes a range of health issues, including gastrointestinal diseases, immuno-oncological diseases, and metabolic diseases. Over the last decade, gut microbiome therapeutics have largely relied on untarg...

The smart and connected homes market is developing quickly and attracting a wide range of companies. Enabled by the Internet of Things (IoT), the journey towards smart and connected homes depends heavily on end user acceptance. This is a crucial factor for market participants to gain customer trust based on value propositions and suitable regional ...

Software-defined automation (SDA) represents a paradigm shift in industrial and manufacturing control systems that addresses traditional operational technology (OT) architectures' limitations. As proprietary, hardware-intensive automation systems reach the end of their life cycles, they increasingly hinder innovation, scalability, and adaptability ...

23 Oct 2020  |  Global  |  Market Research

Supply Chain Optimization and Decentralized Manufacturing to Expand the Contract Cell and Gene Therapy Manufacturing Market, 2020–2026

Automation Deployed to Contain Cost of Goods Sold and Vector Manufacturing Standardization will Create New Growth Opportunities

Infographics

×

The cell and gene therapy segment is one of the fastest growing segments in the biopharmaceutical space. While the science behind the therapy has grown by leaps and bounds on the back of decades worth of research, manufacturing has unfortunately lagged behind. To fully harness the curative potential of these therapies and ensure greater reach and a...

This study introduces the Mega Trends influencing the global automatic identification and data capture market. The market is segmented into radio frequency identification, biometrics, and barcodes. Market valuations and revenue forecasts are provided along with key industry trends, technology trends, and end-user and vertical market trends. Global...

23 Oct 2020  |  North America  |  Market Research

Access to New Therapy Areas to Drive Major Growth in the Global Biosimilars Market, 2020–2026

Outsourced Manufacturing of the Complex Third Wave of Biosimilars to Spark New Growth Opportunities

Infographics

×

Key Issues Addressed

In this research service, the Transformational Health team at Frost & Sullivan provides critical insights into the global biosimilar industry, highlighting the key growth opportunities, market revenue forecasts, and trends that will influence the industry with the emergence of the third wave of biosimilars. The global third-wave biosimilars market ...

The bio‑CDMO industry is entering an era of accelerated growth driven by the global shift toward complex biologics, including monoclonal antibodies, antibody-drug conjugates (ADCs), cell and gene therapies, recombinant proteins, and advanced vaccines. Large molecules are projected to record a 10.3% CAGR between 2025 and 2031, signaling sustained de...

20 Jun 2022  |  Global  |  Frost Radar

Frost Radar™: Carbon Capture, Utilization, and Storage—2022

A Benchmarking System to Spark Companies to Action - Innovation that Fuels New Deal Flow and Growth Pipelines

Infographics

×

The carbon capture, utilization, and storage (CCUS) market is in the growth phase, with many innovative technologies and business models being applied to remediate emissions at existing facilities. Most projects are in either a design or pilot phase (in operation but at a relatively small scale). Large-scale commercial operations in most cases are...

As cell and gene therapy (CGT) moves from ultra-rare indications to more common indications, manufacturing capabilities will have to expand to support the commercial requirements of these diseases. Contract research organizations (CROs) can play a critical role in long-term genetic analysis and monitor safety and efficacy up to 15 years after treat...